14th European Congress of Clinical Microbiology and Infectious ...

Meeting Hall IV
10.00 – 12.00
Diarrhoeal
diseases
12.15 – 13.45
ESGNI
Business
meeting
2 nd Floor 3 rd Floor
Meeting Hall V South Hall Chamber Hall
10.00 – 12.00
Macrolides and
inflammation
modulation
in respiratory
tract infections
Pliva
12.15 – 13.45
ESGARAB
Business
meeting
10.00 – 12.00
New strategies
in the manag.
of fungal
infections
Fujisawa
4th Floor
Conference Hall
10.00 – 12.00
Emerging
infectious
diseases
p. 25 p. 25 p. 25
14.00 – 15.00
14.00 – 15.00
14.00 – 15.00
� Molecular Anaerobic infections MRSA – Have all
pathogenesis of ID
(Young Investigator and antibiotic treat- of us lost the
Award lectures) ment failures battle?
14.00 – 15.00
Sexually
transmitted
diseases
14.00 – 15.00
Pharmaco kinetics
and pharmacodynamics
p. 49 p. 49 p. 49 p. 50 p. 50
15.30 – 17.30
Antibiotic
resistance
mechanisms
15.30 – 17.30
Diagnosis of TB
and atypical
pneumonia
infections in an
enlarged Europe
BD
12.15 – 13.45
EUCAST
Business
meeting
15.30 – 17.30
Susceptibility
testing and
its role in
therapy and
epidemiology
10.00 – 12.00
Communicable
infections:
surveillance
systems and
public health
issues
15.30 – 17.30
Paediatric
infections and
vaccines
15.30 – 17.30
Tropical and
parasitic
diseases
07.15 – 08.15
07.15 – 08.15
07.15 – 08.15
07.15 – 08.15
MDR tuberculosis: Cost-effective use
Clonal analysis of Diagnosis and
risk factors and of the clinical micro-
bacterial management of
management biology laboratory
populations chronic Lyme disease
p. 56 p. 56 p. 56 p. 56
10.00 – 12.00
The international
dimension of
epidemiological
typing
12.15 – 13.45
ESGEM
Business
meeting
14.00 – 16.00
Tick-borne
encephalitis
10.00 – 12.00
Influence of the
regulatory
environment on
antimicrobial
resistance
Bayer
14.00 – 16.00
In vitro studies of
antimicrobial
agents, fitness &
virulence factors
of bacteria
Official Symposia
Oral Sessions
Satellite- & Integrated Symposia
Meet-the-Expert Sessions, Teaching Courses & Workshops
Business Meetings
07.15 – 08.15
07.15 – 08.15
07.15 – 08.15
07.15 – 08.15
How to manage Screening and
Laboratory diagno- Controversies in
current rickettsial laboratory
sis of emerging pediatric
diseases detection of MRSA
p. 43 p. 43
viral diseases
p. 43
08.30 – 09.30
Harnessing RNA �
interference for
therapy
immunisation
p. 43
10.00 – 12.00
Auditing
antimicrobial
prescriptions
in Europe
12.15 – 13.45
ESGAP
Business
meeting
p. 44
p. 44 p. 47 p. 47 p. 45 p. 46
p. 52 p. 55 p. 51 p. 52 p. 53
10.00 – 12.00
Hepatitis
10.00 – 12.00
Epidemiology
and management
of communityacquired
pneumonia
p. 58 p. 60 p. 58 p. 59 p. 59
p. 25 p. 25
14.00 – 16.00
Mycobacterial
infections:
diagnosis and
epidemiology
14.00 – 16.00
Infection in the
immunocom -
promised host:
diagnostic tools,
treatment and
monitoring
p. 62 p. 62 p. 63 p. 64
Registration: 07.00 – 18.00
Registration: 07.00 – 16.30
Foyers
Exhibition: 09.00 – 18.00
Exhibition: 09.00 – 14.00
Poster Session III: 12.00 – 13.00 / Poster Session IV: 13.00 – 14.00
Poster Session V: 12.00 – 13.00 / Poster Session VI: 13.00 – 14.00
p. 000
07
08
09
10
11
12
13
14
15
16
17
07
08
09
10
11
12
13
14
15
16
www.escmid.org/eccmid2004
Monday,
May 3, 2004
Tuesday,
May 4, 2004
page 21